找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Katatone und dyskinetische Syndrome; Hanns Hippius (Direktor der Psychiatrischen Klinik Conference proceedings 1989 Springer-Verlag Berlin

[復(fù)制鏈接]
樓主: 珍愛
11#
發(fā)表于 2025-3-23 13:47:32 | 只看該作者
H. Sassesents the consequence of the interaction of some agent, usually a hormone, a neurotransmitter or a drug, with the myocyte, which ultimately causes an increase in the interaction of the actin and myosin filaments. Increased interaction of the filaments is measurable in the intact heart muscle as an
12#
發(fā)表于 2025-3-23 13:55:58 | 只看該作者
13#
發(fā)表于 2025-3-23 19:31:06 | 只看該作者
14#
發(fā)表于 2025-3-23 23:56:57 | 只看該作者
15#
發(fā)表于 2025-3-24 04:29:30 | 只看該作者
16#
發(fā)表于 2025-3-24 08:41:15 | 只看該作者
D. Schmidty, their results are often important for the subsequent development of treatment plans. For example, treatment plans for challenging behavior based on reinforcement typically include the provision of the identified functional reinforcer for desired behavior and extinction (withholding the functional
17#
發(fā)表于 2025-3-24 12:24:38 | 只看該作者
H. J. M?llerl overview, research on mental health disorders, report writing, the role of treatment planning, and treatment associated with mental health disorders. The Second Edition?builds on the knowledge base by providing the most current information on all aspects of each topic. This unique volume addresses
18#
發(fā)表于 2025-3-24 18:22:42 | 只看該作者
H. Lauter,H. Sauery, their results are often important for the subsequent development of treatment plans. For example, treatment plans for challenging behavior based on reinforcement typically include the provision of the identified functional reinforcer for desired behavior and extinction (withholding the functional
19#
發(fā)表于 2025-3-24 21:19:52 | 只看該作者
C. Spiess-Kieferar against cancer, tumor resistance is still a clinical challenge, which makes the late diagnosis a drawback that must be surpassed. In this scenario, nanotechnology brought the opportunity to rationalize new and powerful strategies to improve diagnosis and therapeutic outcomes. One promising approa
20#
發(fā)表于 2025-3-25 00:05:00 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 23:27
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
云梦县| 仙居县| 南平市| 富源县| 任丘市| 德钦县| 西乡县| 靖西县| 雷山县| 榆中县| 衡阳县| 贺兰县| 英德市| 洮南市| 和硕县| 绥宁县| 鹤庆县| 通许县| 永宁县| 金山区| 安宁市| 通化县| 旬阳县| 中山市| 南通市| 临夏县| 无锡市| 平潭县| 泸溪县| 南郑县| 吴忠市| 崇文区| 南京市| 永泰县| 汤阴县| 随州市| 盐边县| 壤塘县| 晋宁县| 乡城县| 文山县|